J. Bardos

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

C. Gaul, M. Rettiganti, D. Kudrow, 2021, Journal of pain research.

Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review

D. Dodick, P. Goadsby, M. Ashina, 2022, Headache.

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

R. Conley, D. Dodick, S. Aurora, 2020, Cephalalgia : an international journal of headache.

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache

C. Gaul, M. Rettiganti, D. Kudrow, 2020, Headache.

Efficacy of galcanezumab in patients with episodic cluster headaches and a history of preventive treatment failure

A. Ambrosini, M. Rettiganti, A. Tockhorn-Heidenreich, 2021, Cephalalgia Reports.

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

J. Schoenen, M. Láinez, M. Bangs, 2021, Headache.

Anti-CGRP in cluster headache therapy: a response

S. Aurora, R. Wenzel, J. Bardos, 2020, Neurological Sciences.

Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

R. Conley, D. Dodick, S. Aurora, 2019, The New England journal of medicine.